Universe Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Total Assets Growth & History (UPC)
Universe Pharmaceuticals's total assets was $69.30B for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $69.30B | $1.35B | +1.99% |
| 2024 | 2024-09-30 | $67.95B | $67.91B | +162762.16% |
| 2023 | 2023-09-30 | $41.7M | −$17.8M | −29.92% |
| 2022 | 2022-09-30 | $59.5M | −$10.6M | −15.12% |
| 2021 | 2021-09-30 | $70.1M | $41.3M | +143.52% |
| 2020 | 2020-09-30 | $28.8M | — | — |
Universe Pharmaceuticals quarterly total assets
Q4.20
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | $71.5M | −$9.2M | −11.41% |
| Q4 2025 | 2025-09-30 | $69.30B | $1.35B | +1.99% |
| Q2 2025 | 2025-03-31 | $80.7M | $31.2M | +63.19% |
| Q4 2024 | 2024-09-30 | $67.95B | $67.91B | +162762.16% |
| Q2 2024 | 2024-03-31 | $49.4M | −$20.9M | −29.75% |
| Q4 2023 | 2023-09-30 | $41.7M | −$17.8M | −29.92% |
| Q2 2023 | 2023-03-31 | $70.4M | −$997,830 | −1.40% |
| Q4 2022 | 2022-09-30 | $59.5M | −$10.6M | −15.12% |
| Q2 2022 | 2022-03-31 | $71.4M | — | — |
| Q4 2021 | 2021-09-30 | $70.1M | $41.3M | +143.52% |
| Q4 2020 | 2020-09-30 | $28.8M | — | — |
Universe Pharmaceuticals total assets trends
Over the last five fiscal years, Universe Pharmaceuticals's total assets increased from $28.8M to $69.30B, a change of $69.27B. The latest reported quarter, Q2 2026, shows $71.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗